Home LiteratureArticle Details
PMID: 12915532 Published · ppublish English Journal Article

Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Journal of virology ·Vol. 77 ·No. 17 ·2003-09-00 ·Pages 9156-72

Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A

Abstract

Respiratory syncytial virus (RSV) is an important cause of respiratory tract disease worldwide, especially in the pediatric population. For viruses in general, apoptotic death of infected cells is a mechanism for reducing virus replication. Apoptosis can also be an important factor in augmenting antigen presentation and the host immune response. We examined apoptosis in response to RSV infection of primary small airway cells, primary tracheal-bronchial cells, and A549 and HEp-2 cell lines. The primary cells and the A549 cell line gave generally similar responses, indicating their appropriateness as models in contrast to HEp-2 cells. With the use of RNase protection assays with probes representing 33 common apoptosis factors, we found strong transcriptional activation of both pro- and antiapoptotic factors in response to RSV infection, which were further studied at the protein level and by functional assays. In particular, RSV infection strongly up-regulated the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its functional receptors death receptor 4 (DR4) and DR5. Furthermore, RSV-infected cells became highly sensitive to apoptosis induced by exogenous TRAIL. These findings suggest that RSV-infected cells in vivo are susceptible to killing through the TRAIL pathway by immune cells such as natural killer and CD4(+) cells that bear membrane-bound TRAIL. RSV infection also induced several proapoptotic factors of the Bcl-2 family and caspases 3, 6, 7, 8, 9, and 10, representing both the death receptor- and mitochondrion-dependent apoptotic pathways. RSV also mediated the strong induction of antiapoptotic factors of the Bcl-2 family, especially Mcl-1, which might account for the delayed induction of apoptosis in RSV-infected cells in the absence of exogenous induction of the TRAIL pathway.

MeSH Terms
Apoptosis/physiology Apoptosis Regulatory Proteins Caspases/genetics,metabolism Cell Line Cells, Cultured Enzyme Activation Epithelial Cells/pathology,virology Humans Kinetics Lung/pathology,virology Membrane Glycoproteins/genetics,physiology Myeloid Cell Leukemia Sequence 1 Protein Neoplasm Proteins/genetics Proto-Oncogene Proteins c-bcl-2/genetics RNA, Messenger/genetics,metabolism Receptors, TNF-Related Apoptosis-Inducing Ligand Receptors, Tumor Necrosis Factor/genetics Respiratory Syncytial Virus Infections/etiology,genetics,pathology,virology Respiratory Syncytial Virus, Human/pathogenicity,physiology TNF-Related Apoptosis-Inducing Ligand Tumor Necrosis Factor-alpha/genetics,physiology Up-Regulation Virus Replication
Chemicals
Apoptosis Regulatory Proteins Membrane Glycoproteins Myeloid Cell Leukemia Sequence 1 Protein Neoplasm Proteins Proto-Oncogene Proteins c-bcl-2 RNA, Messenger Receptors, TNF-Related Apoptosis-Inducing Ligand Receptors, Tumor Necrosis Factor TNF-Related Apoptosis-Inducing Ligand TNFRSF10A protein, human TNFRSF10B protein, human TNFSF10 protein, human Tumor Necrosis Factor-alpha Caspases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kotelkin Alexander
Respiratory Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Prikhod'ko Elena A
Cohen Jeffrey I
Collins Peter L
Bukreyev Alexander
References (79)
79 references, click to expand
  1. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.
    J Virol. 2001 Nov;75(22):10800-7 PMID: 11602721
  2. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model.
    J Mol Med (Berl). 2001 Oct;79(10):587-93 PMID: 11692156
  3. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.
    J Biol Chem. 2001 Dec 7;276(49):46639-46 PMID: 11583996
  4. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway.
    J Biol Chem. 2002 Jan 4;277(1):492-501 PMID: 11687577
  5. Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.
    J Virol. 2002 Mar;76(6):3007-14 PMID: 11861866
  6. Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family.
    Virology. 2002 Jan 20;292(2):258-71 PMID: 11878929
  7. How melanoma cells evade trail-induced apoptosis.
    Nat Rev Cancer. 2001 Nov;1(2):142-50 PMID: 11905805
  8. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
    J Interferon Cytokine Res. 2002 Feb;22(2):269-79 PMID: 11911810
  9. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
    Oncogene. 2002 Apr 4;21(15):2283-94 PMID: 11948412
  10. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.
    J Virol. 2002 Jun;76(11):5654-66 PMID: 11991994
  11. Human caspase 12 has acquired deleterious mutations.
    Biochem Biophys Res Commun. 2002 May 3;293(2):722-6 PMID: 12054529
  12. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways.
    J Infect Dis. 2002 Nov 1;186(9):1199-206 PMID: 12402188
  13. Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.
    Eur J Pharm Biopharm. 2002 Nov;54(3):263-9 PMID: 12445555
  14. Mortality associated with influenza and respiratory syncytial virus in the United States.
    JAMA. 2003 Jan 8;289(2):179-86 PMID: 12517228
  15. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines.
    J Immunol. 1999 Jul 1;163(1):130-6 PMID: 10384108
  16. Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-converting enzyme gene expression but does not cause apoptosis.
    J Virol. 1998 May;72(5):4498-502 PMID: 9557748
  17. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.
    J Biol Chem. 1998 Jun 5;273(23):14363-7 PMID: 9603945
  18. Death receptors: signaling and modulation.
    Science. 1998 Aug 28;281(5381):1305-8 PMID: 9721089
  19. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.
    J Immunol. 1998 Sep 1;161(5):2195-200 PMID: 9725211
  20. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.
    J Exp Med. 1998 Oct 5;188(7):1359-68 PMID: 9763615
  21. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function.
    J Immunol. 1998 Nov 1;161(9):4467-71 PMID: 9794367
  22. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.
    Genes Dev. 1999 Feb 15;13(4):382-7 PMID: 10049353
  23. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    J Immunol. 1999 Mar 1;162(5):2639-47 PMID: 10072506
  24. Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes.
    Cytogenet Cell Genet. 1988;48(1):19-24 PMID: 3180844
  25. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.
    Vaccine. 1990 Oct;8(5):497-502 PMID: 2251875
  26. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3516-20 PMID: 7682708
  27. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.
    Cancer Res. 1993 Oct 1;53(19):4701-14 PMID: 8402648
  28. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins.
    Biochim Biophys Acta. 1994 Apr 5;1197(1):63-93 PMID: 8155692
  29. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection.
    Virology. 1999 Apr 25;257(1):198-207 PMID: 10208933
  30. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.
    J Exp Med. 1999 May 3;189(9):1451-60 PMID: 10224285
  31. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
    Cancer Res. 1999 Jun 1;59(11):2747-53 PMID: 10364001
  32. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.
    J Immunol. 1999 Jul 15;163(2):920-6 PMID: 10395688
  33. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9136-41 PMID: 10430908
  34. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    J Immunol. 1999 Aug 15;163(4):1906-13 PMID: 10438925
  35. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.
    Mol Cell Biol. 1999 Sep;19(9):5923-9 PMID: 10454539
  36. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity.
    Cytokine. 1999 Sep;11(9):664-72 PMID: 10479402
  37. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
    Nature. 1998 Mar 5;392(6671):86-9 PMID: 9510252
  38. BCL-2 gene family and the regulation of programmed cell death.
    Cancer Res. 1999 Apr 1;59(7 Suppl):1693s-1700s PMID: 10197582
  39. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
    J Exp Med. 1995 Nov 1;182(5):1545-56 PMID: 7595224
  40. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.
    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11563-7 PMID: 8524804
  41. Identification and characterization of a new member of the TNF family that induces apoptosis.
    Immunity. 1995 Dec;3(6):673-82 PMID: 8777713
  42. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.
    J Biol Chem. 1996 May 31;271(22):12687-90 PMID: 8663110
  43. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6.
    J Infect Dis. 1996 Aug;174(2):262-7 PMID: 8699053
  44. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation.
    J Virol. 1996 Dec;70(12):8773-81 PMID: 8971006
  45. Inhibition of viral replication reverses respiratory syncytial virus-induced NF-kappaB activation and interleukin-8 gene expression in A549 cells.
    J Virol. 1996 Dec;70(12):9079-82 PMID: 8971048
  46. The receptor for the cytotoxic ligand TRAIL.
    Science. 1997 Apr 4;276(5309):111-3 PMID: 9082980
  47. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin.
    Virology. 1997 Jun 9;232(2):369-78 PMID: 9191851
  48. An antagonist decoy receptor and a death domain-containing receptor for TRAIL.
    Science. 1997 Aug 8;277(5327):815-8 PMID: 9242610
  49. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.
    Science. 1997 Aug 8;277(5327):818-21 PMID: 9242611
  50. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.
    EMBO J. 1997 Sep 1;16(17):5386-97 PMID: 9311998
  51. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.
    J Exp Med. 1997 Oct 6;186(7):1165-70 PMID: 9314565
  52. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.
    Nat Genet. 1997 Oct;17(2):141-3 PMID: 9326928
  53. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.
    J Virol. 1997 Dec;71(12):8973-82 PMID: 9371553
  54. Characterization of two receptors for TRAIL.
    FEBS Lett. 1997 Oct 27;416(3):329-34 PMID: 9373179
  55. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.
    Immunity. 1997 Dec;7(6):813-20 PMID: 9430226
  56. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.
    Immunity. 1997 Dec;7(6):821-30 PMID: 9430227
  57. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.
    Nat Med. 1998 Feb;4(2):232-4 PMID: 9461199
  58. Viruses and apoptosis.
    Annu Rev Microbiol. 1999;53:577-628 PMID: 10547702
  59. Measles virus induces functional TRAIL production by human dendritic cells.
    J Virol. 2000 Jan;74(1):556-9 PMID: 10590149
  60. Respiratory syncytial virus infection induces expression of the anti-apoptosis gene IEX-1L in human respiratory epithelial cells.
    J Infect Dis. 2000 Mar;181(3):824-30 PMID: 10720500
  61. CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.
    J Virol. 2000 Apr;74(8):3455-63 PMID: 10729118
  62. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).
    Mol Cell Biol. 2000 Apr;20(8):2687-95 PMID: 10733571
  63. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    J Exp Med. 2000 May 15;191(10):1721-34 PMID: 10811865
  64. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
    Immunity. 2000 Jun;12(6):599-609 PMID: 10894160
  65. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
    Cancer Res. 2000 Jul 1;60(13):3542-9 PMID: 10910067
  66. Reovirus-induced apoptosis is mediated by TRAIL.
    J Virol. 2000 Sep;74(17):8135-9 PMID: 10933724
  67. Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells.
    Blood. 2000 Sep 1;96(5):1756-63 PMID: 10961874
  68. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.
    J Virol. 2000 Oct;74(19):9317-21 PMID: 10982380
  69. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.
    J Infect Dis. 2000 Nov;182(5):1331-42 PMID: 11010838
  70. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus.
    J Cell Biochem. 2001;80(3):441-54 PMID: 11135374
  71. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
    Biochem Biophys Res Commun. 2001 Jan 26;280(3):788-97 PMID: 11162590
  72. Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro.
    Virology. 2001 Mar 30;282(1):48-55 PMID: 11259189
  73. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.
    Nat Immunol. 2000 Nov;1(5):398-401 PMID: 11062499
  74. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
    J Immunol. 2001 May 1;166(9):5407-15 PMID: 11313377
  75. Host defense, viruses and apoptosis.
    Cell Death Differ. 2001 Feb;8(2):113-26 PMID: 11313713
  76. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Oncogene. 2001 Apr 19;20(17):2122-33 PMID: 11360196
  77. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.
    J Exp Med. 2001 Jul 16;194(2):113-26 PMID: 11457886
  78. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.
    J Virol. 2001 Oct;75(19):8875-87 PMID: 11533151
  79. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Cancer Res. 2001 Oct 1;61(19):7339-48 PMID: 11585775
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-09-00
Pages
9156-72
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC187410
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com